These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
170 related items for PubMed ID: 8757208
1. Improvement of quality of life by treatment with cetirizine in patients with perennial allergic rhinitis as determined by a French version of the SF-36 questionnaire. Bousquet J, Duchateau J, Pignat JC, Fayol C, Marquis P, Mariz S, Ware JE, Valentin B, Burtin B. J Allergy Clin Immunol; 1996 Aug; 98(2):309-16. PubMed ID: 8757208 [Abstract] [Full Text] [Related]
2. Effect of cetirizine on symptom severity and quality of life in perennial allergic rhinitis. Skoner DP, LaForce CF, Nathan RA, Urdaneta ER, Zielinski MA, Sacavage SD, Franklin KB, Wu MM. Allergy Asthma Proc; 2014 Aug; 35(4):338-45. PubMed ID: 24992553 [Abstract] [Full Text] [Related]
3. Further improvement of quality of life by cetirizine in perennial allergic rhinitis as a function of treatment duration. Burtin B, Duchateau J, Pignat JC, Donnelly F, Bousquet J. J Investig Allergol Clin Immunol; 2000 Aug; 10(2):66-70. PubMed ID: 10879992 [Abstract] [Full Text] [Related]
5. Efficacy and safety of levocetirizine on symptoms and health-related quality of life of children with perennial allergic rhinitis: a double-blind, placebo-controlled randomized clinical trial. Potter PC, Paediatric Levocetirizine Study Group. Ann Allergy Asthma Immunol; 2005 Aug; 95(2):175-80. PubMed ID: 16136768 [Abstract] [Full Text] [Related]
6. The comparison of the efficacy and safety of cetirizine, oxatomide, ketotifen, and a placebo for the treatment of childhood perennial allergic rhinitis. Lai DS, Lue KH, Hsieh JC, Lin KL, Lee HS. Ann Allergy Asthma Immunol; 2002 Dec; 89(6):589-98. PubMed ID: 12487225 [Abstract] [Full Text] [Related]
7. The comparison of cetirizine, levocetirizine and placebo for the treatment of childhood perennial allergic rhinitis. Lee CF, Sun HL, Lu KH, Ku MS, Lue KH. Pediatr Allergy Immunol; 2009 Aug; 20(5):493-9. PubMed ID: 19175892 [Abstract] [Full Text] [Related]
8. The health-related quality of life effects of once-daily cetirizine HCl in patients with seasonal allergic rhinitis: a randomized double-blind, placebo-controlled trial. Noonan MJ, Raphael GD, Nayak A, Greos L, Olufade AO, Leidy NK, Champan D, Kramer B. Clin Exp Allergy; 2003 Mar; 33(3):351-8. PubMed ID: 12614450 [Abstract] [Full Text] [Related]
9. Early treatment of perennial rhinitis with budesonide or cetirizine and its effect on long-term outcome. Rinne J, Simola M, Malmberg H, Haahtela T. J Allergy Clin Immunol; 2002 Mar; 109(3):426-32. PubMed ID: 11897986 [Abstract] [Full Text] [Related]
10. A 12-week placebo-controlled study of rupatadine 10 mg once daily compared with cetirizine 10 mg once daily, in the treatment of persistent allergic rhinitis. Fantin S, Maspero J, Bisbal C, Agache I, Donado E, Borja J, Mola O, Izquierdo I, international Rupatadine study group. Allergy; 2008 Jul; 63(7):924-31. PubMed ID: 18588560 [Abstract] [Full Text] [Related]
11. Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis. Bachert C, Bousquet J, Canonica GW, Durham SR, Klimek L, Mullol J, Van Cauwenberge PB, Van Hammée G, XPERT Study Group. J Allergy Clin Immunol; 2004 Oct; 114(4):838-44. PubMed ID: 15480324 [Abstract] [Full Text] [Related]
12. Double-blind study of cetirizine and loratadine versus placebo in patients with allergic rhinitis. Nunes C, Ladeira S. J Investig Allergol Clin Immunol; 2000 Oct; 10(1):20-3. PubMed ID: 10780795 [Abstract] [Full Text] [Related]
13. Comparative study of cetirizine and terfenadine versus placebo in the symptomatic management of seasonal allergic rhinitis. Lockey RF, Widlitz MD, Mitchell DQ, Lumry W, Dockhorn R, Woehler T, Grossman J. Ann Allergy Asthma Immunol; 1996 May; 76(5):448-54. PubMed ID: 8630719 [Abstract] [Full Text] [Related]
14. Efficacy and safety of bilastine 20 mg compared with cetirizine 10 mg and placebo in the treatment of perennial allergic rhinitis. Sastre J, Mullol J, Valero A, Valiente R, Bilastine Study Group. Curr Med Res Opin; 2012 Jan; 28(1):121-30. PubMed ID: 22077106 [Abstract] [Full Text] [Related]
15. Evaluation of the effect of Lactobacillus paracasei (HF.A00232) in children (6-13 years old) with perennial allergic rhinitis: a 12-week, double-blind, randomized, placebo-controlled study. Lin WY, Fu LS, Lin HK, Shen CY, Chen YJ. Pediatr Neonatol; 2014 Jun; 55(3):181-8. PubMed ID: 24269033 [Abstract] [Full Text] [Related]
16. Efficacy of montelukast for treating perennial allergic rhinitis. Philip G, Williams-Herman D, Patel P, Weinstein SF, Alon A, Gilles L, Tozzi CA, Dass SB, Reiss TF. Allergy Asthma Proc; 2007 Jun; 28(3):296-304. PubMed ID: 17619558 [Abstract] [Full Text] [Related]
17. Comparative outdoor study of the efficacy, onset and duration of action, and safety of cetirizine, loratadine, and placebo for seasonal allergic rhinitis. Meltzer EO, Weiler JM, Widlitz MD. J Allergy Clin Immunol; 1996 Feb; 97(2):617-26. PubMed ID: 8621847 [Abstract] [Full Text] [Related]
18. Assessment of quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 Health Status Questionnaire. Bousquet J, Bullinger M, Fayol C, Marquis P, Valentin B, Burtin B. J Allergy Clin Immunol; 1994 Aug; 94(2 Pt 1):182-8. PubMed ID: 8064070 [Abstract] [Full Text] [Related]
19. Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children. Singh-Franco D, Ghin HL, Robles GI, Borja-Hart N, Perez A. Clin Ther; 2009 Aug; 31(8):1664-87. PubMed ID: 19808127 [Abstract] [Full Text] [Related]
20. Assessment of the efficacy and safety of three dose levels of cetirizine given once daily in children with perennial allergic rhinitis. Jobst S, van den Wijngaart W, Schubert A, van de Venne H. Allergy; 1994 Sep; 49(8):598-604. PubMed ID: 7653736 [Abstract] [Full Text] [Related] Page: [Next] [New Search]